Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter H van Geffen

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Respiratory Medicine|September 12, 2020
Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trialWouter H van Geffen, Orestes A Carpaij, Lotte F Westbroek, et al.
Clinical Lung Cancer|July 9, 2020
Nationwide Real-world Cohort Study of First-line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor-mutated Non-small-cell Lung CancerRolof G P Gijtenbeek, Ronald A M Damhuis, Harry J M Groen, et al.
Respiratory Research|November 14, 2009
Increased levels of (class switched) memory B cells in peripheral blood of current smokersCorry-Anke Brandsma, Machteld N Hylkema, Marie Geerlings, et al.
Breathe (Sheffield, England)|April 14, 2020
The electronic nose: emerging biomarkers in lung cancer diagnosticsWouter H van Geffen, Kevin Lamote, Adrien Costantini, et al.
The European Respiratory Journal|January 14, 2012
Differential switching to IgG and IgA in active smoking COPD patients and healthy controlsCorry-Anke Brandsma, Huib A M Kerstjens, Wouter H van Geffen, et al.
ERJ Open Research|August 16, 2023
ERS International Congress 2022: highlights from the Thoracic Oncology AssemblyMaria Joana Catarata, Wouter H Van Geffen, Radhika Banka, et al.
Cancer Treatment Reviews|June 9, 2020
Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic reviewHaiyan Zeng, Lizza E L Hendriks, Wouter H van Geffen, et al.
The Lancet Regional Health. Europe|February 23, 2023
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry studyRolof G P Gijtenbeek, Ronald A M Damhuis, Anthonie J van der Wekken, et al.
Breathe (Sheffield, England)|September 18, 2025
The current state of ultrasound training in pulmonary residency programmes in the Netherlands: an educational reviewWytze S de Boer, Carlijn Veldman, Krista L Parlevliet, et al.
Respiration; International Review of Thoracic Diseases|June 22, 2017
Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve TreatmentWouter H van Geffen, Karin Klooster, Jorine E Hartman, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Respiratory Medicine|September 12, 2020
Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trialWouter H van Geffen, Orestes A Carpaij, Lotte F Westbroek, et al.
Clinical Lung Cancer|July 9, 2020
Nationwide Real-world Cohort Study of First-line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor-mutated Non-small-cell Lung CancerRolof G P Gijtenbeek, Ronald A M Damhuis, Harry J M Groen, et al.
Respiratory Research|November 14, 2009
Increased levels of (class switched) memory B cells in peripheral blood of current smokersCorry-Anke Brandsma, Machteld N Hylkema, Marie Geerlings, et al.
Breathe (Sheffield, England)|April 14, 2020
The electronic nose: emerging biomarkers in lung cancer diagnosticsWouter H van Geffen, Kevin Lamote, Adrien Costantini, et al.
The European Respiratory Journal|January 14, 2012
Differential switching to IgG and IgA in active smoking COPD patients and healthy controlsCorry-Anke Brandsma, Huib A M Kerstjens, Wouter H van Geffen, et al.
ERJ Open Research|August 16, 2023
ERS International Congress 2022: highlights from the Thoracic Oncology AssemblyMaria Joana Catarata, Wouter H Van Geffen, Radhika Banka, et al.
Cancer Treatment Reviews|June 9, 2020
Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic reviewHaiyan Zeng, Lizza E L Hendriks, Wouter H van Geffen, et al.
The Lancet Regional Health. Europe|February 23, 2023
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry studyRolof G P Gijtenbeek, Ronald A M Damhuis, Anthonie J van der Wekken, et al.
Breathe (Sheffield, England)|September 18, 2025
The current state of ultrasound training in pulmonary residency programmes in the Netherlands: an educational reviewWytze S de Boer, Carlijn Veldman, Krista L Parlevliet, et al.
Respiration; International Review of Thoracic Diseases|June 22, 2017
Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve TreatmentWouter H van Geffen, Karin Klooster, Jorine E Hartman, et al.
Pageof 7